manilatimes

Biolojic Design Earns Preclinical Milestone from Teva for First AI-Designed Multibody in Autoimmune Disease, TEV ‘325 (formerly BD9)

- TEV ‘325, which targets IL-13 and TSLP, is being studied for the treatment of TH2-driven inflammatory diseases such as asthma and atopic dermatitis WASHINGTON and NESS ZIONA, Israel, March 25, 2026 ...
IEEE

A Geometric Algorithm for Robust Multibody Inertial Parameter Identification

Abstract: Notwithstanding the seemingly straightforward nature of the inertial parameter identification problem for multibody systems-the most common formulation is as a linear least-squares ...
BioSpace

Biolojic Design Earns Preclinical Milestone from Teva for First AI-Designed Multibody in Autoimmune Disease, TEV ‘325 (formerly BD9)

WASHINGTON and NESS ZIONA, Israel, March 25, 2026 (GLOBE NEWSWIRE)-- Biolojic Design, a biotechnology company that uses AI to transform antibodies into multifunctional, programmable medicines, today ...
IEEE

Accessing From the Sky: A Tutorial on UAV Communications for 5G and Beyond

Abstract: Unmanned aerial vehicles (UAVs) have found numerous applications and are expected to bring fertile business opportunities in the next decade. Among various enabling technologies for UAVs, ...